Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07526948 · ClinicalTrials.gov registry record · Phase 4
Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV
A Phase 4 study, sponsored by Albert Einstein College of Medicine.
- Not yet
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
NCT07526948 is a Phase 4 study that has not yet begun recruiting, run by Albert Einstein College of Medicine. The registered enrollment target is 62 participants.
The verdict
NCT07526948, a Phase 4 study, has not yet begun recruiting, sponsored by Albert Einstein College of Medicine.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
Study Summary
This is a research study about the effects of vaginal estradiol compared to moisturizer on vaginal symptoms of menopause and the microbiome in women with HIV. This research study aims to understand how vaginal products affect the aging of the female genital tract in women living with HIV who are menopausal or perimenopausal and have vaginal or urinary symptoms. There is a comparison group of women who are living without HIV. Participants with HIV and vaginal or urinary menopausal symptoms (e.g., dryness, irritation, soreness, itching, pain with sex, dysuria, urgency, or frequent urinary tract infections) will be asked to apply vaginal estradiol or a vaginal moisturizer (Replens). Participants who have vaginal or urinary menopausal symptoms and do not have HIV will receive vaginal estradiol.
Interventions
- DRUG Vaginal estradiol tablets
- OTHER Vaginal moisturizer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2031-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07526948
The ClinicalTrials.gov registry entry for NCT07526948 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vaginal estradiol tablets is the first listed.
NCT07526948 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07526948 about?
NCT07526948 is a clinical study titled "Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV". This is a research study about the effects of vaginal estradiol compared to moisturizer on vaginal symptoms of menopause and the microbiome in women with HIV. This research study aims to understand how vaginal products affect the aging of the female genital tract in women living with HIV who are men...
What is the current status of trial NCT07526948?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2026-06-01. Estimated completion is 2031-06-30.
What interventions are being tested in trial NCT07526948?
The interventions under investigation include: Vaginal estradiol tablets (DRUG), Vaginal moisturizer (OTHER).
Who is sponsoring clinical trial NCT07526948?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.